Patents by Inventor Philippe Chan-Tchi-Song

Philippe Chan-Tchi-Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hafnia alvei impact on regulation of appetite and metabolic syndrome aspects
    Publication number: 20210008125
    Abstract: The present invention relates to method of preventing, treating or attenuating obesity-related manifestations in a human or non-human mammal subject in need thereof, said method comprising orally administering to the subject a composition comprising an effective amount Hafnia alvei probiotics; wherein said obesity-related parameters are selected from the group of hyperphagia, increased fat mass on lean mass ratio, increased waist circumference, postprandial hyperglycemia, fasting hyperglycemia and hypercholesterolemia.
    Type: Application
    Filed: June 16, 2020
    Publication date: January 14, 2021
    Inventors: Serguei Fetissov, Emmanuelle De, Naouel Tennoune, Jonathan Breton, Philippe Chan-Tchi-Song, Pierre Dechelotte, Romain Legrand, Gregory Lambert
  • Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
    Patent number: 10729770
    Abstract: The present invention relates to ClpB expressing bacteria and their impact on obesity. The present invention relates to bacterial ClpB protein and ClpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one ClpB expressing bacterium as well as probiotics not expressing ClpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: August 4, 2020
    Assignees: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN, UNIVERSITE DE ROUEN, TARGEDYS
    Inventors: Serguei Fetissov, Emmanuelle De, Naouel Tennoune, Jonathan Breton, Philippe Chan-Tchi-Song, Pierre Dechelotte, Romain Legrand, Gregory Lambert
  • Bacterial influence on regulation of appetite via ClpB protein mimicry of alpha-MSH
    Publication number: 20180369378
    Abstract: The present invention relates to CIpB expressing bacteria and their impact on obesity. The present invention relates to bacterial CIpB protein and CIpB expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one CIpB expressing bacterium as well as probiotics not expressing CIpB protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.
    Type: Application
    Filed: July 11, 2018
    Publication date: December 27, 2018
    Inventors: Serguei Fetissov, Emmanuelle De, Naouel Tennoune, Jonathan Breton, Philippe Chan-Tchi-Song, Pierre Dechelotte, Romain Legrand, Gregory Lambert
  • BACTERIAL INFLUENCE OF HOST FEEDING AND EMOTION VIA CLPB PROTEIN MIMICRY OF A-MSH
    Publication number: 20160339094
    Abstract: The present invention relates to bacterial Clp B protein and Clp B expressing bacteria and their impact on diseases or disorders related to reduced appetite, increased appetite and/or anxiety. The invention further relates to compositions related to bacterial ClpB protein and to its use in the immunization against a disorder related to reduced appetite and/or anxiety.
    Type: Application
    Filed: December 4, 2014
    Publication date: November 24, 2016
    Inventors: Sergueï FETISSOV, Naouel TENNOUNE, Philippe CHAN-TCHI-SONG, Emmanuelle DE, Pierre DECHELOTTE
  • BACTERIAL INFLUENCE ON REGULATION OF APPETITE VIA CLPB PROTEIN MIMICRY OF ALPHA-MSH
    Publication number: 20160313348
    Abstract: The present invention relates to bacterial Clp B protein and Clp B expressing bacteria and their impact on eating disorders. The invention further relates to compositions comprising antibiotic directed against at least one Clp B expressing bacterium as well as probiotics not expressing Clp B protein and their use in the treatment or prevention of eating disorders. The invention also relates to diagnostic tools for determining whether a subject is likely to respond to a method of treating eating disorders and to methods of immunization against eating disorders.
    Type: Application
    Filed: December 4, 2014
    Publication date: October 27, 2016
    Inventors: Serguei Fetissov, Emmanuelle De, Naouel Tennoune, Jonathan Breton, Philippe Chan-Tchi-Song, Pierre Dechelotte, Romain Legrand